Increased levels of soluble CD27 in the cerebrospinal fluid are not diagnostic for leptomeningeal involvement by lymphoid malignancies

Annals of Hematology

Volumn 81, Issue 4, 2002, Pages 187-191

  van den Bent, M J ^a   Lamers, C H J ^a   van't Veer, M B ^a   Smitt, P A E Sillevis ^a   Bolhuis, R L H ^a   Gratama, J W ^a  

^a ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

Central nervous system; Leptomeningeal lymphomatosis; Leptomeningeal malignancy; Lymphoma; sCD27

Indexed keywords

CD19 ANTIGEN; CD27 ANTIGEN; CD3 ANTIGEN; CD4 ANTIGEN; CD45 ANTIGEN; CD5 ANTIGEN; CD8 ANTIGEN; CYTOTOXIC AGENT; IMMUNOGLOBULIN M; METHOTREXATE; TUMOR MARKER;

ANTIGEN EXPRESSION; ARTICLE; B CELL LYMPHOMA; CANCER CELL; CEREBROSPINAL FLUID ANALYSIS; CHRONIC LYMPHATIC LEUKEMIA; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; FOLLOW UP; HEMATOLOGIC MALIGNANCY; HERPES SIMPLEX; HERPES ZOSTER; HUMAN; INFECTION COMPLICATION; LYMPHOCYTE; LYMPHOPROLIFERATIVE DISEASE; MAJOR CLINICAL STUDY; MENINGEAL METASTASIS; NEUROLOGIC DISEASE; NEURORADIOLOGY; NONHODGKIN LYMPHOMA; PRIORITY JOURNAL; SENSITIVITY AND SPECIFICITY; SYMPTOMATOLOGY;

ANTIGENS, CD27; DIAGNOSTIC ERRORS; HUMANS; LEUKEMIA, B-CELL, CHRONIC; LYMPHOMA, B-CELL; MENINGEAL NEOPLASMS; PREDICTIVE VALUE OF TESTS; SOLUBILITY; TUMOR MARKERS, BIOLOGICAL;

EID: 0036935347     PISSN: 09395555     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00277-002-0448-5     Document Type: Article

References (23)

1. Beyne P, Lisovoski F, Got L, Ayache P, Delacoux E (1995) Beta-2 microglobulin in cerebrospinal fluid in neurology. Presse Med 24:1071-1074
2. Biesterfeld S, Bernhard B, Bamborschke S, Bocking A (1993) DNA single cell cytometry in lymphocytic pleocytosis of the cerebrospinal fluid. Acta Neuropathol 86:428-432
3. Ernerudh J, Olsson T, Berlin G, Gustafsson B, Karlsson H (1986) Cell surface markers for diagnosis of central nervous system involvement in lymphoproliferative disease. Ann Neurol 20:610-615
4. 2-microglobulin in lymphoproliferative and other neoplastic disease of the central nervous system. Arch Neurol 44:915-920
5. Finn WG, Peterson LC, James C, Goolsby CL (1998) Enhanced detection of malignant lymphoma in the cerebrospinal fluid by multiparameter flow cytometry. Am J Clin Pathol 110:341-346
6. Freilich RJ, Krol G, DeAngelis LM (1995) Neuroimaging and cerebrospinal fluid cytology in the diagnosis of leptomeningeal metastasis. Ann Neurol 38:51-57
7. Hintzen RQ, de Jong R, Hack CE, Chamuleau M, de Vries EFR, ten Berghe IJM, Borst J, van Lier RAW (1991) A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex. J Immunol 147:29-35
8. Hintzen RQ, van Lier RAW, Kuijpers KC, Baars PA, Schaasberg W, Lucas CJ, Polman CH (1991) Elevated levels of a soluble form of the T cell activation antigen CD27 in cerebrospinal fluid of multiple sclerosis patients. J Neuroimmunol 35: 211-217
9. Hovestadt A, Henzen-Logmans SC, Vecht CJ (1990) Immunohistochemical analysis of the cerebrospinal fluid for carciomatous and lymphomatous leptomeningitis. Br J Cancer 62: 653-654
10. 2-microglobulin levels in meningeal involvement by malignancy. Pathology 22:20-23
11. Kersten MJ, Evers LM, Dellemijn PLI, Portegies P, Hintzen RQ, van Lier RAW, von dem Borne AEGK, van Oers RHJ (1996) Elevation of cerebrospinal fluid soluble CD-27 levels in patients with meningeal localization of lymphoid malignancies. Blood 87:1985-1989
12. Maurer D, Holter W, Majdic O, Fischer GF, Knapp W (1990) CD27 expression by a distinct subpopulation of human B lymphocytes. Eur J Immunol 20:2679-2682
13. 2-microglobulin determination. N Engl J Med 303:718-722
14. Rajantie J, Koskiniemia M, Siimes MA, Salonen E, Vahere AI (1989) CSF fibronectin in Burkitt's lymphoma: an early marker for CNS involvement. Eur J Haematol 42:313-314
15. Recht L, Straus DJ, Cirrincione C, Thaler HT, Posner JB (1988) Central nervous system metastases from non-Hodgkin's lymphoma: treatment and prophylaxis. Am J Med 84:425-435
16. Rhodes CH, Glantz MJ, Glantz L, Lekos A, Sorenson GD, Honsinger C, Levy NB (1996) A comparison of polymerase chain reaction of cerebrospinal fluid and conventional cytology in the diagnosis of lymphomatous meningitis. Cancer 77:543-548
17. v Oostenbrugge RJ, Hopman AHN, Lenders MH, v Heerde P, Arends JW, Ramaekers FSC, Twijnstra A (1997) Detection of malignant cells in cerebrospinal fluid using fluorescence in situ hybridization. J Neuropathol Exp Neurol 56:743-748
18. van Lier RAW, Borst J, Vroom TH, Klein H, van Mourik P, Zeijlemaker WP, Melief CJM (1987) Tissue distribution and functional properties of Tp55 (CD27), a novel T-cell differentiation antigen. J Immunol 139:1589
19. van Oers MHJ, Pals ST, Evers LM, van der Schoot CE, Koopman G, Bonfrer JMG, Hintzen RQ, von dem Borne AEGK. van Lier RAW (1993) Expression and release of CD27 in human B-cell malignancies. Blood 82:3430-3436
20. Weller M, Sommer N, Stevnes A, Wiethölter H (1990) Increased intrathecal synthesis of fibronectin in bacterial and carcinomatous meningitis. Acta Neurol Scand 82:138-142
21. Weller M, Stevens A, Sommer N, Melms A, Dichgans J, Wiethölter H (1991) Comparative analysis of cytokine patterns in immunological, infectious and oncological neurological disorders. J Neurol Sci 104:215-221
22. Weller M, Stevens A, Sommer N, Schabet M, Wiethölter H (1992) Humoral CSF parameters in the differential diagnosis of hematologic CNS neoplasia. Acta Neurol Scand 86:129-133
23. Young RC, Howser DM, Anderson T, Fisher RI, Jaffe E, DeVita VT (1979) Central nervous system complications of non-Hodgkin's lymphoma. The potential role for prophylactic therapy. Am J Med 66:435-443